Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
Campbell, Jonathon R, Trajman, Anete, Cook, Victoria J, Johnston, James C, Adjobimey, Menonli, Ruslami, Rovina, Eisenbeis, Lisa, Fregonese, Federica, Valiquette, Chantal, Benedetti, Andrea, Menzies, DJournal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(19)30575-4
Date:
December, 2019
File:
PDF, 1.00 MB
2019
File converter
More search results
More benefits 
